Cravacin (Deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Cerca
Aggiornamenti recenti
Altre storie
JogaJog https://jogajog.com.bd